Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
SARS-CoV-2 infection stimulates a complex activation of the immune system. Eosinophils belong to the host's defense equipment against respiratory viruses. In the first phase of the infection, eosinophils contribution is probably appropriate and beneficial, as they facilitate the suppression of...
Saved in:
Main Authors: | Daniele Pala (Author), Marco Pistis (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunopathological mechanisms involved in SARS-CoV-2 infection
by: Sávio Breno P. Brito, et al.
Published: (2020) -
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges
by: Idris Nasir Abdullahi, et al.
Published: (2021) -
Understanding the immunopathology of SARS-CoV-2 infection - the key to successful COVID-19 therapy
by: Ewa Brzezińska-Błaszczyk, et al.
Published: (2021) -
Immunopathology of SARS-CoV-2 Infection: A Focus on T Regulatory and B Cell Responses in Children Compared with Adults
by: Gabriele Di Sante, et al.
Published: (2022) -
Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023)